EUVIMEDEUVIMED entdecken
Crossref

Compliance with the DASH diet and risk of all-cause and cardiovascular mortality in patients with myocardial infarction

Nadia E Bonekamp, Esther Cruijsen, Frank Lj Visseren, Yvonne T van der Schouw, Johanna M Geleijnse, Charlotte Koopal

Clinical Nutrition · 2023

DOI: 10.1016/j.clnu.2023.06.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nutrition, 2023. Verfasst von Nadia E Bonekamp und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Dietary Approaches To Stop Hypertension, Cardiovascular Diseases, Myocardial Infarction, Hypertension. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: The Dietary Approaches to Stop Hypertension (DASH) diet has been shown to effectively reduce blood pressure and body weight, but its effectiveness for reducing (cardiovascular) mortality rates has never been assessed in a clinical trial. Causal effects of dietary interventions are difficult to measure, due to practical limitations of randomized controlled diet trials. Target trial emulation can be used to improve causal inference in observational data. The aim of this study was to emulate a target trial assessing the relationship between compliance with the DASH diet and cardiovascular and all-cause mortality risk in patients with established CVD. METHODS: Using data from the Alpha Omega Cohort, we emulated a DASH diet trial in patients with a history of myocardial infarction (MI). Inverse probability of treatment weighting (IPTW) was used to balance confounders over DASH-compliant and non-DASH-compliant participants. Hazard ratios (HRs) were estimated with IPT-weighted Cox models. RESULTS: Of 4365 patients (79% male, median age 69 years, >80% treated with lipid- and blood pressure-lowering medication), 598 were classified as DASH-compliant (compliance score ≥5 out of 9). During a median follow-up of 12.4 years, 2035 deaths occurred of which 903 (44%) were of cardiovascular origin. DASH compliance was not associated with all-cause mortality (HR 0.92, 95%CI 0.0.80-1.06) and cardiovascular mortality (HR 0.90, 95%CI 0.72-1.11). CONCLUSIONS: In an emulated target trial on the DASH diet in the Alpha Omega cohort no relation was found between DASH compliance and risk of all-cause and cardiovascular mortality in patients with a history of MI. The DASH diet's effects may have been modified in this population by concomitant use of blood pressure-lowering medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary Approaches To Stop HypertensionCardiovascular DiseasesMyocardial InfarctionHypertensionHumansMaleAgedFemaleDietPatient ComplianceBlood Pressure

Stichwörter der Autor:innen

Cardiovascular diseaseDASH dietInverse probability of treatment weightingNutritionPropensity scoreTarget trial emulation

Autor:innen und Institutionen

  • Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands.
  • Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: F.L.J.Visseren@umcutrecht.nl.
  • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Bonekamp, N. E., Cruijsen, E., Visseren, F. L., van der Schouw, Y. T., Geleijnse, J. M., & Koopal, C. (2023). Compliance with the DASH diet and risk of all-cause and cardiovascular mortality in patients with myocardial infarction. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2023.06.033

Vancouver

Bonekamp NE, Cruijsen E, Visseren FL, van der Schouw YT, Geleijnse JM, Koopal C. Compliance with the DASH diet and risk of all-cause and cardiovascular mortality in patients with myocardial infarction. Clinical Nutrition. 2023. doi:10.1016/j.clnu.2023.06.033

BibTeX
@article{Bonekamp2023,
  author = {Bonekamp, Nadia E and Cruijsen, Esther and Visseren, Frank Lj and van der Schouw, Yvonne T and Geleijnse, Johanna M and Koopal, Charlotte},
  title = {Compliance with the DASH diet and risk of all-cause and cardiovascular mortality in patients with myocardial infarction},
  journal = {Clinical Nutrition},
  year = {2023},
  doi = {10.1016/j.clnu.2023.06.033}
}
Kostenlos starten →